SQM(SH:688138)2025-04-29 16:45Financial Performance - The company's operating revenue for Q1 2025 was CNY 298,536,172.31, representing a year-on-year increase of 9.83% compared to CNY 271,823,375.62 in the same period last year[3] - The net profit attributable to shareholders for the same period was CNY 51,742,160.88, reflecting a growth of 4.34% from CNY 49,590,830.56 in the previous year[3] - The net profit after deducting non-recurring gains and losses was CNY 47,118,076.16, which is a 5.41% increase from CNY 44,700,665.25 in the prior year[3] - The diluted earnings per share for the reporting period was CNY 0.20, an increase of 5.26% from CNY 0.19 in the previous year[4] - Total operating revenue for Q1 2025 reached ¥298,536,172.31, an increase of 9.9% compared to ¥271,823,375.62 in Q1 2024[17] - Net profit for Q1 2025 was ¥51,763,992.23, representing a 4.4% increase from ¥49,590,830.56 in Q1 2024[18] - Basic earnings per share for Q1 2025 were ¥0.20, compared to ¥0.19 in Q1 2024[19] Cash Flow - The net cash flow from operating activities was CNY 56,205,347.70, showing a slight decrease of 2.29% compared to CNY 57,520,338.05 in the same period last year[3] - Cash inflow from operating activities in Q1 2025 totaled ¥348,071,567.43, an increase from ¥327,690,514.17 in Q1 2024[20] - The net cash flow from operating activities was $56,205,347.70, a decrease of 2.29% compared to $57,520,338.05 in the previous period[21] - The total cash and cash equivalents at the end of the period amounted to $365,302,067.75, compared to $404,122,969.89 at the end of the previous period, reflecting a decrease of 9.59%[21] - The company reported a total of $10,522,443.26 in net increase in cash and cash equivalents, a significant decrease from $61,239,769.89 in the previous period[21] Assets and Liabilities - The total assets at the end of the reporting period were CNY 2,837,851,031.33, an increase of 3.47% from CNY 2,742,767,482.75 at the end of the previous year[4] - The company's total liabilities as of the latest report were ¥1,299,391,651.83, compared to ¥1,259,560,773.28 previously[16] - Non-current liabilities increased to ¥639,040,955.60 from ¥548,872,235.87[16] - The company's short-term borrowings were reported at RMB 215,023,753.15, a slight decrease from RMB 216,766,813.14, reflecting a reduction of about 0.8%[14] Research and Development - Research and development expenses totaled CNY 11,247,564.28, which is a decrease of 6.39% from CNY 12,015,170.14 in the previous year[4] - The proportion of R&D expenses to operating revenue was 3.77%, down from 4.42% in the same period last year, a decrease of 0.65 percentage points[4] - Research and development expenses for Q1 2025 were ¥11,247,564.28, slightly down from ¥12,015,170.14 in Q1 2024[17] Government Support and Future Outlook - The company received government subsidies amounting to CNY 5,441,278.82, which positively impacted the net profit for the period[5] - The company has not disclosed any new product developments or technological advancements during this reporting period[10] - There are no significant mergers or acquisitions reported in the latest financial update[10] - The company has not provided specific future guidance or market expansion strategies in the current report[10] - The company plans to implement new accounting standards starting in 2025, which may affect future financial reporting[21]